Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
Samuel R Schnittman(Icahn School of Medicine at Mount Sinai), Steven Grinspoon(Massachusetts General Hospital), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Brandon Davis(Ragon Institute of MGH, MIT and Harvard), Romina Chinchay(University of Houston), Wonyeong Jung(Ragon Institute of MGH, MIT and Harvard), Pamela S. Douglas(Duke University), Douglas A. Lauffenburger(Harvard University), Evelynne S. Fulda(Cancer Research And Biostatistics), Jessica Shih-Lu Lee(Ragon Institute of MGH, MIT and Harvard), Sally Shin(Ragon Institute of MGH, MIT and Harvard), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Galit Alter(Moderna Therapeutics (United States)), Marissa R Diggs(Harvard University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Anandi N. Sheth(Emory University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Markella V. Zanni(Harvard University), Françoise Giguel(Harvard University), Heather J. Ribaudo(Cancer Research And Biostatistics)
Cited by 3
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease: Executive Summary
|Circulation|2012|2.4k
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
|New England Journal of Medicine|2012|2.3k